Back to Search Start Over

Allelic variants within the ABO blood group phenotype confer protection against critical COVID-19 hospital presentation

Authors :
Jelinek, Herbert F.
Mousa, Mira
Alkaabi, Nawal
Alefishat, Eman
Daw Elbait, Gihan
Kannout, Hussein
AlHumaidan, Hiba
Selvaraj, Francis Amirtharaj
Imambaccus, Hala
Weber, Stefan
Uddin, Maimunah
Abdulkarim, Fatema
Mahboub, Bassam
Tay, Guan
Alsafar, Habiba
Jelinek, Herbert F.
Mousa, Mira
Alkaabi, Nawal
Alefishat, Eman
Daw Elbait, Gihan
Kannout, Hussein
AlHumaidan, Hiba
Selvaraj, Francis Amirtharaj
Imambaccus, Hala
Weber, Stefan
Uddin, Maimunah
Abdulkarim, Fatema
Mahboub, Bassam
Tay, Guan
Alsafar, Habiba
Source :
Research outputs 2022 to 2026
Publication Year :
2022

Abstract

Introduction: Coronavirus disease 2019 (COVID-19) disease severity differs widely due to numerous factors including ABO gene-derived susceptibility or resistance. The objective of this study was to investigate the association of the ABO blood group and genetic variations of the ABO gene with COVID-19 severity in a heterogeneous hospital population sample from the United Arab Emirates, with the use of an epidemiological and candidate gene approach from a genome-wide association study (GWAS). Methods: In this cross-sectional study, a total of 646 participants who tested positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) were recruited from multiple hospitals and population-based (quarantine camps) recruitment sites from March 2020 to February 2021. The participants were divided into two groups based on the severity of COVID-19: noncritical (n = 453) and critical [intensive care unit (ICU) patients] (n = 193), as per the COVID-19 Reporting and Data System (CO-RADS) classification. The multivariate logistic regression analysis demonstrated the association of ABO blood type as well as circulating anti-A antibodies and anti-B antibodies as well as A and B antigens, in association with critical COVID-19 hospital presentation. A candidate gene analysis approach was conducted from a GWAS where we examined 240 single nucleotide polymorphisms (SNPs) (position in chr9: 136125788-136150617) in the ABO gene, in association with critical COVID-19 hospital presentation. Results: Patients with blood group O [odds ratio (OR): 0.51 (0.33, 0.79); p = 0.003] were less likely to develop critical COVID-19 symptoms. Eight alleles have been identified to be associated with a protective effect of blood group O in ABO 3'untranslated region (UTR): rs199969472 (p = 0.0052), rs34266669 (p = 0.0052), rs76700116 (p = 0.0052), rs7849280 (p = 0.0052), rs34039247 (p = 0.0104), rs10901251 (p = 0.0165), rs9411475 (p = 0.0377), and rs13291798 (p = 0.0377). Conclusion: Our findings

Details

Database :
OAIster
Journal :
Research outputs 2022 to 2026
Notes :
application/pdf, Research outputs 2022 to 2026
Publication Type :
Electronic Resource
Accession number :
edsoai.on1314876651
Document Type :
Electronic Resource